Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 3,735.00
+35.00 (0.95%)
Nov 2, 2026, 3:30 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 171.99 billion as of October 30, 2026. It is the 23,513th most valuable company in the world and the 920th biggest in South Korea. Its market cap has decreased by 29.53% in one year.
Market Cap
171.99B
Enterprise Value
118.12B
Revenue
2.42B
Global Rank
Country Rank
#920 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 29, 2005, Helixmith's market cap has decreased from 238.64B to 171.99B, a decrease of -27.93%. That is a compound annual growth rate of -1.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 171.99B | -39.95% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDIPOST | 316.20B |
| SillaJen | 279.88B |
| Genomictree | 244.71B |
| HLB Therapeutics | 219.91B |
| GC Genome | 215.22B |
| Bioneer | 175.77B |
| NeoImmuneTech | 155.82B |
| GC Cell | 151.77B |